基于社区的参与性研究中年妇女心血管疾病预防:一个系统性审查
1Nursing Department, College of Nursing and Health Sciences, Jazan University, Jazan, Saudi Arabia.
Heart international
|July 25, 2025
概括
基于社区的参与型研究 (CBPR) 通过文化相关的干预措施,有效降低中年女性心血管疾病 (CVD) 风险. 这种方法通过解决服务不足人群的差异来改善健康公平.
科学领域:
- 公共卫生 公共卫生
- 健康 公平 卫生 公平
- 基于社区的研究.
背景情况:
- 心血管疾病 (CVD) 是女性的主要健康问题,特别是那些处于生育年龄和中年妇女.
- 黑人女性和来自较低社会经济背景的女性患心血管疾病的风险不成比例地高.
- 生理变化,压力和系统障碍加剧了女性心血管疾病风险.
研究的目的:
- 评估基于社区的参与性研究 (CBPR) 在减轻中年妇女心脏病风险方面的有效性.
- 强调文化相关性在健康干预成功中的关键作用.
- 在不同的人群中确定成功的CVD风险降低策略的关键决定因素.
主要方法:
- 在PubMed,Scopus和Web of Science进行了遵循PRISMA指南的系统文献搜索.
- 分析了15项研究,包括RCT,PBPR和混合方法研究.
- 干预的重点是饮食,体育活动,压力管理和社区参与,结果包括血压,胆固醇,BMI和葡萄糖水平.
主要成果:
- 通过CBPR干预,系统性 (7 mmHg) 和扩张性 (4 mmHg) 血压,LDL胆固醇 (10-15 mg/dL) 和BMI (0.5-1.2 kg/m2) 显著降低.
- HDL胆固醇增加了5-8毫克/分升.
- 文化定制的干预措施,强调饮食变化,团体炼和同行支持,改善坚持和持续的行为变化,强调文化相关性,信任和社区所有权的重要性.
结论:
- 基于社区的参与型研究 (CBPR) 显示出降低心血管疾病风险和解决健康差异的巨大潜力.
- 扩大CBPR倡议和实施长期干预措施对于加强健康公平至关重要.
- 在文化相关,社区驱动的研究中持续努力,可以为不同的人口带来持久的健康益处.
相关概念视频
01:26Coronary Artery Disease IV: Preventive Measures
35
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
35
01:23Assessment of the Cardiovascular System I: Subjective Data
467
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
467
01:27Coronary Artery Disease V: Interprofessional Care
33
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
33
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
337
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
337
01:26Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29